U.S. Anti-Vascular Endothelial Growth Factor Therapeutics Market Size & Outlook
The anti-vascular endothelial growth factor therapeutics market in the United States is expected to reach a projected revenue of US$ 8,582.4 million by 2030. A compound annual growth rate of -1.3% is expected of the United States anti-vascular endothelial growth factor therapeutics market from 2025 to 2030.
- Pharmaceuticals
- Ophthalmology Drugs
- Anti-Vascular Endothelial Growth Factor Therapeutics Market Outlook
- Ophthalmology Drugs